In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma.
In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma. Am J Clin Pathol. 2009 Oct; 132(4):500-5.